TY - JOUR
T1 - Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin
AU - Khosla, Sareena
AU - Crawley, Jacqueline
PY - 1988
Y1 - 1988
N2 - A new antagonist of the peripheral cholecystokinin receptor, L-364,718, was found to block the reductions in food intake and exploratory activity induced by intraperitoneal administration of cholecystokinin octapeptide sulfate. L-364,718 significantly reversed the cholecystokinin-induced reduction in feeding at doses of 10 μg/kg - 10 mg/kg i.p. L-364,718 significantly reversed the cholecystokinin-induced reduction in exploratory activity at doses of 500 ng/kg - 10 mg/kg i.p. The time course of antagonist activity of L-364,718 was immediate to 90 minutes after intraperitoneal administration. L-364,718 had no significant effect on food intake or exploratory activity when administered alone, over the dose range of 100 ng/kg-10 mg/kg i.p. This compound appears to be at least one hundred times more potent than proglumide or benzotript as an antagonist of the behavioral effects of peripherally administered cholecystokinin.
AB - A new antagonist of the peripheral cholecystokinin receptor, L-364,718, was found to block the reductions in food intake and exploratory activity induced by intraperitoneal administration of cholecystokinin octapeptide sulfate. L-364,718 significantly reversed the cholecystokinin-induced reduction in feeding at doses of 10 μg/kg - 10 mg/kg i.p. L-364,718 significantly reversed the cholecystokinin-induced reduction in exploratory activity at doses of 500 ng/kg - 10 mg/kg i.p. The time course of antagonist activity of L-364,718 was immediate to 90 minutes after intraperitoneal administration. L-364,718 had no significant effect on food intake or exploratory activity when administered alone, over the dose range of 100 ng/kg-10 mg/kg i.p. This compound appears to be at least one hundred times more potent than proglumide or benzotript as an antagonist of the behavioral effects of peripherally administered cholecystokinin.
UR - http://www.scopus.com/inward/record.url?scp=0023704921&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023704921&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(88)90678-9
DO - 10.1016/0024-3205(88)90678-9
M3 - Article
C2 - 3336275
AN - SCOPUS:0023704921
VL - 42
SP - 153
EP - 159
JO - Life Sciences
JF - Life Sciences
SN - 0024-3205
IS - 2
ER -